- 更多网络例句与长春新碱相关的网络例句 [注：此内容来源于网络，仅供参考]
-
The results demonstrated that the intracellular pH change was different when the Hela cells was treated with different anti-tumor drugs, some would caused intracellular acidification, some would caused ntracellular basification, and some would barely caused pH change. The single living Hela cells uptaken with the ratiometric pH nanosensor was also imaged with laser confocal microscope, which were treated with anti-tumor drugs.
通过利用该纳米传感器对硫酸长春新碱诱导后的Hela细胞内pH变化的活体、原位、实时监测，发现在硫酸长春新碱诱导引起凋亡的Hela细胞中，细胞内的pH值由诱导前的7.11酸化为6.51，并且在一定的浓度和时间范围内，硫酸长春新碱诱导后细胞内的酸化率与诱导药物的浓度和诱导时间成正相关关系。
-
Such as Vincristine Sulfate, Vinorelbine Bitartrate, NHDC and Hesperidin Methyl Chalcone.
例如硫酸长春新碱、酒石酸长春瑞宪，NHDC。
-
The presence of granulocytopenia or thrombocytopenia at the start of treatment does not contraindicate Vincristin therapy.
治疗开始时出现 wWw.8tTt8.coM 粒细胞减少或血小板减少，并不禁忌用长春新碱治疗。
-
V The presence of granulocytopenia or thrombocytopenia at the start of treatment does not contraindicate Vincristin therapy.
治疗开始时出现粒细胞减少或血小板减少，并不禁忌用长春新碱治疗。
-
The presence of granulocytopenia or thrombocytopenia at the start of treat ment does not contraindicate Vincristin therapy.
治疗开始时出现粒细胞减少或血小板减少，并不禁忌用长春新碱治疗。
-
EOH3'I5Onk/L The presence of granulocytopenia or thrombocytopenia at the start of treatment does not contraindicate Vincristin therapy.
治疗开始时出现粒细胞减少或血小板减少，并不禁忌用长春新碱治疗。
-
The method using periwinkle cells to cultivate and produce vinblastine and vincristine can stably realize the industrialized production of vinblastine and vincristine, and the production cost is rather low, the culture period is short, and the production is insusceptible to the natural environment and weather, so the year-round production can be realized.
本发明的方法用长春花细胞培养生产长春碱和长春新碱，可稳定的实现长春碱和长春新碱的工业化生产，并且其生产成本较低，培养周期短，不受自然环境以及气候的影响，可以实现周年生产。
-
The stable clones are further identified by RT-PCR and Western blot; 6 MTT assay is used to investigate the effect of ZNRD1 on the cell growth of cells (AGS, SGC7901, MKN28, NIH3T3, GES-1); 7 Soft agar assay is used to investigate the effect of ZNRD1 on the clonality of cells (AGS, MKN28); 8 Nude mice assay is used to investigate the effect of ZNRD1 on the cell growth of gastric cancer cells (AGS, MKN28); 9 Flow cytometry is used to investigate the effect of ZNRD1 on the cell cycle distribution of cells (AGS, MKN28, NIH3T3, GES-1); 10 Flow cytometry is used to investigate the effect of ZNRD1 on the cell apoptosis of cells (AGS, MKN28, NIH3T3); 11 MTT assay is used to investigate the effect of ZNRD1 on the drug sensitivity of cancer cells (SGC7901, SGC7901/VCR, HL-60, HL-60/VCR) in vitro; 12 SRCA is used to investigate the effect of ZNRD1 on the drug sensitivity of gastric cancer cells (SGC7901, SGC7901/VCR) in vivo; 13 Flow cytometry is used to investigate the effect of ZNRD1 on adriamycin accumulation of cancer cells (SGC7901, SGC7901/VCR, HL-60, HL-60/VCR); 14 Transmission electron microscope is used to investigate the effect of ZNRD1 on the sensitivity of SGC7901 cells towards drug-induced apoptosis; 15 Flow cytometry and DNA ladder assay are used to investigate the effect of ZNRD1 on the sensitivity of cells (SGC7901, SGC7901/VCR, HL-60/VCR) towards drug-induced apoptosis; 16 Microarray is used to investigate the profiling of ZNRD1-responsive genes in gastric cancer cells (AGS, MKN28, SGC7901, SGC7901/VCR); 17 RT-PCR and Western blot are used to identify the results of microarray; 18 Reporter gene assay is used to investigate the effect of ZNRD1 on the transcriptional activity of cyclin D1; 19 Reporter gene assay is used to investigate the effect of ZNRD1 on the transcriptional activity of MDR1; 20 Kinase assay is used to investigate the effect of ZNRD1 on the activity of cyclin E-CDK2 kinase; 21 The antisensenucleic acids of p21 is used to inhibit the expression of p21, and flow cytometry is used to investigate the effect of p21 on ZNRD1-induced cell cycle arrest in gastric cancer cells; 22 The antisensenucleic acids of p27 is used to inhibit the expression of p27, and flow cytometry is used to investigate the effect of p27 on ZNRD1-induced cell cycle arrest in gastric cancer cells; 23 Liposome is used to up-regulate the expression of Skp2, and flow cytometry is used to investigate the effect of Skp2 on ZNRD1-induced cell cycle arrest in gastric cancer cells; 24 Western blot is used to investigate the effect of ZNRD1 on the stability of Skp2 and p27 in gastric cancer cells; 25 MVD assay is used to investigate the effect of ZNRD1 on the angiopoietic activity of gastric cancer cells; 26 ELISA is used to investigate the effect of ZNRD1 on the expression of VEGF165 in gastric cancer cells; 27 The roles of DARPP-32 in MDR of gastric cancer cells are investigated using gene transfection, MTT assay, SRCA, flow cytometry and DNA ladder assay.
应用杂交瘤技术制备ZNRD1的首个单克隆抗体；2）利用RT-PCR、Western blot和免疫组化检测ZNRD1在胃癌组织、胃炎组织、正常胃上皮组织、胃癌细胞和正常胃组织上皮细胞中的表达；3）构建ZNRD1的小干扰RNA载体，并测序鉴定；4）利用脂质体将ZNRD1的真核表达载体及其空载体转染胃癌细胞（AGS、SGC7901、MKN28）和小鼠成纤维细胞（NIH3T3），G418筛选后进行鉴定；5）利用脂质体将ZNRD1的小干扰RNA载体及其空载体转染药敏胃癌细胞（SGC7901）、正常胃组织上皮细胞（GES-1）、对长春新碱耐药的胃癌细胞（SGC7901/VCR）、药敏白血病细胞（HL-60）、对长春新碱耐药的白血病细胞（HL-60/VCR），G418筛选后进行鉴定；6）利用MTT实验检测ZNRD1高/低表达对细胞（AGS、SGC7901、MKN28、NIH3T3、GES-1）生长的影响；7）通过软琼脂克隆形成实验检测上调ZNRD1对AGS、MKN28细胞克隆形成能力的影响；8）通过裸鼠成瘤实验检测上调ZNRD1对AGS、MKN28细胞体内成瘤性的影响；9）通过流式细胞仪分析ZNRD1高/低表达对细胞（AGS、MKN28、NIH3T3、GES-1）的细胞周期的影响；10）通过流式细胞仪分析上调ZNRD1对细胞（AGS、MKN28、NIH3T3）的凋亡的影响；11）通过MTT实验检测ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR、HL-60、HL-60/VCR）体外药物敏感性的影响；12）通过肾包膜下移植法检测ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR）体内药物敏感性的影响；13）通过流式细胞仪分析ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR、HL-60、HL-60/VCR）内阿霉素蓄积和泵出的影响；14）通过透射电镜检测上调ZNRD1对SGC7901细胞凋亡敏感性的影响；15）通过流式细胞仪和DNA梯度试验检测ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR、HL-60）凋亡敏感性的影响；16）通过基因芯片检测ZNRD1高/低表达对胃癌细胞内基因表达谱的影响；17）利用RT-PCR、Western blot对基因芯片的结果进行鉴定；18）利用报告基因实验检测ZNRD1对cyclin D1的启动子活性的调节作用；19）利用报告基因实验检测ZNRD1高/低表达对MDR1的启动子活性的调节作用；20）利用激酶试验检测ZNRD1对cyclin E-CDK2 激酶活力的影响；21）利用反义核酸技术抑制p21的表达；通过流式细胞仪检测抑制p21对ZNRD1介导的细胞周期阻滞的影响；22）利用反义核酸技术抑制p27的表达；通过流式细胞仪检测抑制p27对ZNRD1介导的细胞周期阻滞的影响；23）利用脂质体转染法上调Skp2的表达；通过流式细胞仪检测上调Skp2对ZNRD1介导的细胞周期阻滞的影响；24）利用Western blot检测ZNRD1对p27和Skp2的蛋白稳定性的影响；25）利用微血管密度实验检测ZNRD1对AGS、MKN28细胞裸鼠移植瘤微血管形成的影响；26）利用ELISA检测ZNRD1对AGS、MKN28细胞培养上清和移植瘤匀浆中VEGF165含量的影响；27）利用脂质体转染法、MTT实验、肾包膜下移植法、流式细胞仪和DNA梯度试验检测新耐药相关分子DARPP-32对细胞（SGC7901、SGC7901/VCR、对阿霉素耐药的胃癌细胞SGC7901/ADR）多药耐药表型的影响；利用脂质体转染法和MTT实验检测下调ZNRD1对DARPP-32介导的胃癌多药耐药的调控作用。
-
The survival rates of CEM cells cultured with cis-diamminedichicloroplatinum added 24 h later were higher than that cultured with hTERT ASODN and DDP added 24 h later. The survival rates of CEM cells cultured with DDP were similar with that cultured with hTERT SOND and DDP. In morphological observation of apoptotic cells using Giemsa staining, cells treated with DDP or DDP combined with hTERT ASODN ro SODN at 48 h, displayed classic apoptotic changes. Apoptosis rates of CEM cells treated with DDP for 48 h after 24 h of exposure to ASODN significantly increased. There was significant difference in the percentage of apoptotic cells of CEM cells between hTERT ASODN plus DDP and SODN plus DDP or DDP alone, respectively.
结果： hTERT ASODN作用于CEM细胞24 h再加入柔红霉素、长春新碱、足叶乙甙，对细胞生长的抑制分别与单用柔红霉素、长春新碱、足叶乙甙及hTERT正义寡核苷酸联合柔红霉素、长春新碱、足叶乙甙组相比，统计学上无显著差异(P＞0.05)。hTERT反义核酸作用于CEM细胞24 h加入顺铂，再共同作用48 h，CEM活细胞均数为2.318×108 cells/L，与单用顺铂组(3.250×108 cells/L)及hTERT正义核酸联用顺铂组(3.175×108 cells/L)相比，对细胞抑制明显增强(P＜0.05)。hTERT ASODN作用于CEM细胞24 h再加入顺铂作用48 h，细胞出现典型的凋亡形态学改变。hTERT ASODN与2.5 μmol/L顺铂联合作用于CEM细胞48 h的凋亡细胞百分率(19.47%)分别同SODN与顺铂联合作用组(6.97%)、单用顺铂作用组(6.02%)进行比较有显著差异(P＜0.01)。
-
In addition to chloramphenicol, there are dozens of drugs can lead to aplastic anemia, which mainly mercaptopurine, phenyl amino-nitrogen mustard, vincristine, busulfan, medical arsenic trioxide, colchicine, the card Bima yl, chlorine, sulfur C urea, trimethadione and so on.
除了氯霉素，还有数十种药物可以导致再障，其中主要有巯嘌呤、苯丙氨基氮芥、长春新碱、白消安、医用砷剂、秋水仙碱、卡比马唑、氯磺丙脲、三甲双酮等。
- 更多网络解释与长春新碱相关的网络解释 [注：此内容来源于网络，仅供参考]
-
ADM：阿霉素
乳腺癌是实体瘤中化疗对之较有效的,目前对乳腺癌较有效的药物有环磷酰胺(CTX)、氟尿嘧啶(5-FU)、甲氨蝶呤(MTX)、多柔比星(阿霉素)(ADM)、丝裂霉素(MMC)、长春新碱(VCR)、长春花碱(VLB),长春花碱酰胺(VDS)及环基亚硝脲(BCNU),
-
Dehydrate Catharanthine：脱水长春碱
长春新碱 vincristine | 脱水长春碱 Dehydrate Catharanthine | 盐酸小檗碱 Berberine hydrochloride
-
DNR：柔红霉素
1.先天性ALL 可采用长春新碱(VCR)阿糖胞苷(Ara-C)环磷酰胺(CTX)泼尼松(强的松)甲氨蝶呤(MTX)柔红霉素(DNR)门冬酰胺酶(L-ASP)巯嘌呤(6-MP)硫鸟嘌呤(6-TG)等药物治疗诱导方案可用VPVDP或VDCP等组合维持治疗多用巯嘌呤(6-MP)
-
VCR：长春新碱
目的建立鼻咽癌化疗药敏药物的体外筛选方法.方法利用MTT法体外药敏试验检测了48例鼻咽癌(NPC)对7 种临床化疗药物的敏感性.结果 NPC细胞对顺铂(DDP), 5-氟脲嘧啶(5-FU), 长春新碱(VCR),环磷酰胺(CTX), 博来霉素(BLM),
-
VCR vincristine：长春新碱
Va Dent J Virginia Dental Jour-nal 弗吉尼亚牙医学杂志(美国) | VCR vincristine 长春新碱 | VD vertical dimension 垂直距离
-
VCR vincristine：长春新碱(抗肿瘤药)
var: variety变种,种类,品种(生物) | VCR:vincristine长春新碱(抗肿瘤药) | VD: venereal disease 性病
-
VD venereal disease：性病,花柳病
VAMP vincristine,amethopterin,mercaptopurine and prednisone 长春新碱-氨甲蝶呤-巯基嘌呤-强的松(联合疗法) | VD venereal disease 性病,花柳病 | VDEL Venereal Disease Experimental Laboratory 性病实验室
-
thoracentesis：胸腔穿刺术
10. dyspnea 呼吸困难 | 11. thoracentesis 胸腔穿刺术 | 12. vincristine 长春新碱
-
UVJ ureterovesical junction：输尿管膀胱连接部
UUN urine urea nitrogen 尿中尿素氮 | UVJ ureterovesical junction 输尿管膀胱连接部 | VAMP vincristine,amethopterin,mercaptopurine and prednisone 长春新碱-氨甲蝶呤-巯基嘌呤-强的松(联合疗法)
-
VAMP vincristine,amethopterin,mercaptopurine and prednisone：长春新碱-氨甲蝶呤-巯基嘌呤-强的松(联合疗法)
UVJ ureterovesical junction 输尿管膀胱连接部 | VAMP vincristine,amethopterin,mercaptopurine and prednisone 长春新碱-氨甲蝶呤-巯基嘌呤-强的松(联合疗法) | VD venereal disease 性病,花柳病